Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 Transporter-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 Transporter

Published:2020-10-09 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Gao Hai-Ling,Gupta Pranav,Cui Qingbin,Ashar Yunali V.,Wu Zhuo-Xun,Zeng Leli,Lei Zi-Ning,Teng Qiu-Xu,Ashby Charles R.,Guan Yingjun,Chen Zhe-Sheng

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference58 articles.

1. Anticancer agents: Fighting resistance;Sarah;Nat Rev Drug Discovery,2017

2. The multi-factorial nature of clinical multidrug resistance in cancer;Assaraf;Drug Resist Updat,2019

3. Editorial: multidrug resistance in cancer: pharmacological strategies from basic research to clinical issues;Riganti;Front Oncol,2015

4. Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases;Chen;FEBS J,2011

5. Drug resistance in cancer: an overview;Housman;Cancers (Basel),2014

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the future: Innovative design strategies and emerging challenges in HER2-targeted tyrosine kinase inhibitors for cancer therapy;European Journal of Medicinal Chemistry;2024-10

2. Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling;Frontiers in Pharmacology;2024-01-10

3. Small Molecule Inhibitors Targeting the “Undruggable” Survivin: The Past, Present, and Future from a Medicinal Chemist’s Perspective;Journal of Medicinal Chemistry;2023-12-13

4. Integrated multi-omics identified the novel intratumor microbiome-derived subtypes and signature to predict the outcome, tumor microenvironment heterogeneity, and immunotherapy response for pancreatic cancer patients;Frontiers in Pharmacology;2023-09-07

5. Toad venom-derived bufadienolides and their therapeutic application in prostate cancers: Current status and future directions;Frontiers in Chemistry;2023-03-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3